Design and validation of an automated method to detect known adverse drug reactions in MEDLINE: a contribution from

Paul Avillach1, Jean-Charles Dufour, Gayo Diallo

  • 1LESIM, ISPED, University of Bordeaux, Bordeaux, France. avillach@mac.com

Abstract

Insights

This study developed an automated method to identify adverse drug reactions (ADR) in medical literature. The approach achieved high accuracy, demonstrating a valid way to find drug/event associations using MEDLINE and MeSH terms.

Area of Science:

  • Biomedical Informatics
  • Pharmacovigilance
  • Medical Literature Analysis

Background:

  • Adverse drug reactions (ADR) pose a significant public health challenge.
  • Efficiently identifying and confirming drug-event associations in scientific literature is crucial for patient safety.

Purpose of the Study:

  • To automate the search for publications related to adverse drug reactions (ADR).
  • To define optimal search queries and publication thresholds for confirming drug/event associations in MEDLINE.
  • To develop a reliable method for mining established drug-adverse event relationships.

Main Methods:

  • Utilized Medical Subject Headings (MeSH) descriptor and supplementary concept records.
  • Incorporated 'chemically induced' and 'adverse effects' subheadings with 'pharmacological action' knowledge.
  • Validated the approach using an expert-curated dataset of 61 drug/adverse event associations.

Main Results:

  • Achieved 90% sensitivity and 100% specificity with a threshold of three or more publications.
  • Demonstrated recall ranging from 24% to 64% and precision from 93% to 48% for selected drug/event pairs.
  • The automated search effectively filters signals using a MeSH approach.

Conclusions:

  • Presents a validated method for identifying established drug-adverse event relationships in literature.
  • Confirms MEDLINE searching with a MeSH approach as a viable strategy for ADR detection.
  • The developed method is available as a web service for integration into automated systems like the EU-ADR project.

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Drug Toxicity: Overview01:00

Drug Toxicity: Overview

Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...